Liver fibrosis showed a two-phase regression rate during long-term anti-HBV therapy by three-time biopsies assessments.

导出 LinkOut

翻译打印收藏纠错

作者： Shuyan,Chen ^[1] ; Jialing,Zhou ^[1] ; Xiaoning,Wu ^[1] ; Tongtong,Meng ^[1] ; Bingqiong,Wang ^[1] ; Hui,Liu ^[2] ; Tailing,Wang ^[3] ; Xinyan,Zhao ^[1] ; Xinyu,Zhao ^[4] ; Yuanyuan,Kong ^[4] ; Xiaojuan,Ou ^[1] ; Jidong,Jia ^[1] ; Yameng,Sun ^[5] ; Hong,You ^[6]

作者单位： Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, National Clinical Research Center of Digestive Diseases, Beijing, China. ^[1] Department of Pathology, Beijing Youan Hospital, Capital Medical University, Beijing, China. ^[2] Department of Pathology, China-Japan Friendship Hospital, Beijing, China. ^[3] Clinical Epidemiology and EBM Unit, Beijing Friendship Hospital, Capital Medical University, Beijing Clinical Research Institute, Beijing, China. ^[4] Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, National Clinical Research Center of Digestive Diseases, Beijing, China. sunyamenggo@163.com. ^[5] Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, National Clinical Research Center of Digestive Diseases, Beijing, China. youhong30@sina.com. ^[6]

关键词 P-I-R score Antiviral treatment Chronic hepatitis B Cirrhosis Hepatic fibrosis Ishak fibrosis score Ishak-HAI score Reverse SHG/TPEF Serial liver biopsies